Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276818 Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
12/15/2005US20050276812 Antibody-drug conjugates and methods
12/15/2005US20050276805 Antibody molecules having a Fc region with complex N-glycoside-linked sugar chains bound it through an N-acetylglucosamine of the reducing terminal of the sugar chains, which do not contain chains with a fucose bound to the N-acetylglucosamines.
12/15/2005US20050276758 Method for screening agents against human prostate disease
12/15/2005US20050276757 Methods of using ZC1 and ZC3 kinase substrate phosphorylation as biomarkers
12/15/2005US20050276724 Apparatus for mixing and/or testing small volumes of fluids
12/15/2005US20050276696 Methods and apparatus for rotor blade ice detection
12/15/2005US20050276485 Pattern recognition system utilizing an expression profile
12/15/2005US20050276457 Histological assessment
12/15/2005US20050274629 Apparatus and method for integral electrochemical biosensor
12/15/2005US20050274616 Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis
12/15/2005US20050274612 Hybridization detecting unit including an electrode having depression parts and DNA chip including the detecting unit
12/15/2005US20050274172 Airbag inflator performance test system
12/15/2005DE202005011798U1 Test strip for use in manufacturing of electro chemical bio sensor array, has foil covering two electrodes, in order to affect foil with sample for activating bio chemical reaction, and opening provided at periphery of reaction area
12/15/2005DE10227962B4 Grundkörper für einen Bio-Chip, Anordnung zum Auslesen und Vorrichtung zur Hybridisierung Base for a bio-chip device for reading and apparatus for hybridization
12/15/2005DE102005019195A1 Chemische Reaktionspatrone, Verfahren zum Herstellen einer chemischen Reaktionspatrone und Mechanismus zum Betätigen einer chemischen Reaktionspatrone Chemical reaction cartridge, method for producing a chemical reaction cartridge and actuating mechanism of a chemical reaction cartridge
12/15/2005DE102004026508A1 Diagnosing causes of variations in human and animal keratin structures resulting from external and internal effects, microorganisms and contamination
12/15/2005DE102004025967A1 Test method for sensor element, e.g. viscosity sensor for motor oil, by selecting parameter which influences propagation of oscillations in medium
12/15/2005DE102004025224A1 Quantitative dermination of hydrogen sulfide in gases, e.g. for monitoring waste gases, using flow system with biosensor comprising sulfur-oxidizing bacteria immobilized on oxygen sensor and/or pH sensor
12/15/2005DE102004024977A1 Vorrichtung zur in-vivo Charakterisierung von Zellen und Ihre Verwendung Apparatus for in vivo characterization of cells and their use
12/15/2005DE102004024674A1 Mittel und Verfahren zur Diagnose, Prophylaxe und Therapie von Bindegewebserkrankungen Means and methods for diagnosis, prophylaxis and treatment of connective tissue diseases
12/15/2005DE102004024145A1 Microscope slide, has part of flat surface provided with rewritable data carrier e.g. a transponder
12/15/2005DE102004022263A1 Vorrichtung und Verfahren zum Nachweis von molekularen Wechselwirkungen Device and method for the detection of molecular interactions
12/15/2005CA2776050A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2775594A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2572348A1 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
12/15/2005CA2569520A1 Egfr mutations
12/15/2005CA2569502A1 Diagnosing or predicting the course of breast cancer
12/15/2005CA2569487A1 Diagnostic testing process and apparatus incorporating controlled sample flow
12/15/2005CA2569206A1 Assay system with in situ formation of diazo reagent
12/15/2005CA2569202A1 Multigene predictors of response to chemotherapy
12/15/2005CA2569197A1 Method of quickly detecting and/or assaying antigen by fluorescence correlation spectrometry
12/15/2005CA2569100A1 Methods for identifying risk of breast cancer and treatment thereof
12/15/2005CA2569079A1 Methods of screening for cell proliferation or neoplastic disorders
12/15/2005CA2568841A1 Method and device for rapid detection and quantitation of macro and micro matrices
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568780A1 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005CA2568732A1 Methods for predicting and monitoring response to cancer therapy
12/15/2005CA2568405A1 Biomarkers for monitoring inhibition of impdh pathway
12/15/2005CA2568360A1 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
12/15/2005CA2568345A1 Inhibitors of regiii proteins as asthma therapeutics
12/15/2005CA2568252A1 Quantitative lateral flow system and assay
12/15/2005CA2568213A1 Composition and method for the treatment of tauopathies
12/15/2005CA2568162A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2567887A1 Method for screening and compositions for treating cancers
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/15/2005CA2567520A1 Maytansinoid-antibody conjugates
12/15/2005CA2567491A1 Immune response assessment method
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2567293A1 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
12/15/2005CA2567114A1 Nanoscale electronic detection system and methods for their manufacture
12/15/2005CA2566723A1 New intravenous drug administration and blood sampling model in the awake rat
12/15/2005CA2566575A1 Method of screening candidate compounds for susceptibility to biliary excretion
12/15/2005CA2566571A1 Treatment methods utilizing albumin-binding proteins as targets
12/15/2005CA2566506A1 Peptides for inducing a ctl and/or htl response to hepatitis c virus
12/15/2005CA2565801A1 Use of il-17 in the treatment of fertility-related disorders
12/15/2005CA2565549A1 Measuring device and methods for use therewith
12/15/2005CA2562447A1 Methods and apparatus for detection of viral infection
12/15/2005CA2562337A1 Reagents for arsenic meter
12/15/2005CA2560472A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2558963A1 Omi pdz modulators
12/15/2005CA2502031A1 Sensing apparatus for a vehicle
12/14/2005EP1605288A1 Optical element
12/14/2005EP1605267A2 Microarray washing apparatus and method
12/14/2005EP1605266A1 Urothelial cancer tumor marker
12/14/2005EP1605265A1 Non-covalent complexes comprising carbon nanotubes
12/14/2005EP1605264A1 An integrating analysis chip with minimized reactors and its application
12/14/2005EP1605263A2 Methods, composition and kit for measuring expression of a cell-surface
12/14/2005EP1605262A1 Method of identifying inhibitors of cardiac hypertrophy
12/14/2005EP1605261A1 Method of detecting colon cancer marker
12/14/2005EP1605260A2 Method and test kit for determining total organic carbon (TOC)
12/14/2005EP1605254A1 Analyzing tool with exhaust port
12/14/2005EP1605253A1 Biosensor apparatus and method with sample type and volume detection
12/14/2005EP1605248A1 Device for measuring immunochromatography test piece
12/14/2005EP1605246A1 Measuring method, measuring signal output circuit, and measuring apparatus
12/14/2005EP1605245A2 Process for washing array substrates
12/14/2005EP1605063A1 Hybridization detecting unit and DNA chip including the detecting unit
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605046A1 Stably transfected cell lines expressing human GABA-A receptors with the subunit combination alpha-2, beta-3 and gamma-2
12/14/2005EP1605045A2 Polypeptides and nucleic acids encoding same
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1605042A2 Compositions for protein fragment complementation assays to detect biomolecular interactions
12/14/2005EP1604996A2 An allergenic protein complex of natural rubber latex
12/14/2005EP1604993A1 Inhibitors
12/14/2005EP1604689A1 Simultaneous multimodal measurement of physiological function
12/14/2005EP1604682A1 Gonadal function improving agents
12/14/2005EP1604669A1 Use of ATP analogues for treatment of cardiovascular diseases
12/14/2005EP1604668A1 Hepoxilins and modulators of ichthyin for treating skin disorders
12/14/2005EP1604367A2 Reording medium, playback device, recording method, playback method, and computer program
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1604211A2 Identification of therapeutic compounds
12/14/2005EP1604210A2 Method for detecting alzheimer's disease and corresponding peptides and detection reagents
12/14/2005EP1604209A1 Screening assay
12/14/2005EP1604208A1 Method to evaluate the likelihood of development of bone metastasis based on the determination of calcium proteins
12/14/2005EP1604207A2 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
1 ... 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 ... 3937